Clinical trial
Combination Chemotherapy in Treating Patients With Stage III or Stage IV…
NCT00304083 · Sarcoma Alliance for Research through Collaboration, Other · Completed
Key facts
| NCT number | NCT00304083 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Malignant Peripheral Nerve Sheath Tumors |
| Official title | Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated High Grade Malignant Peripheral Nerve Sheath Tumors |
| Lead sponsor | Sarcoma Alliance for Research through Collaboration, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neurofibromatosis Type 1, Sarcoma |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, doxorubicin hydrochloride, etoposide, ifosfamide, conventional surgery, radiation therapy |
| Enrollment | 48 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 1, 2014 |
| Completion | Jun 1, 2014 |
| First posted | Mar 17, 2006 |
| Last update posted | Sep 18, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: